acyclovir
Generic: acyclovir
Labeler: american health packagingDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
american health packaging
Dosage Form
CAPSULE
Routes
Active Ingredients
acyclovir 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68084-107
Product ID
68084-107_28a04db3-edb9-2f5f-e063-6394a90ab2ec
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075677
Marketing Start
2014-02-06
Marketing End
2026-04-30
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68084107
Hyphenated Format
68084-107
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA075677 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-107-01) / 1 CAPSULE in 1 BLISTER PACK (68084-107-11)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "28a04db3-edb9-2f5f-e063-6394a90ab2ec", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["9d16ea0c-5b51-43b8-bf1a-bee84a6a764b"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-107-01) / 1 CAPSULE in 1 BLISTER PACK (68084-107-11)", "package_ndc": "68084-107-01", "marketing_end_date": "20260430", "marketing_start_date": "20140206"}], "brand_name": "ACYCLOVIR", "product_id": "68084-107_28a04db3-edb9-2f5f-e063-6394a90ab2ec", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68084-107", "generic_name": "ACYCLOVIR", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACYCLOVIR", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA075677", "marketing_category": "ANDA", "marketing_end_date": "20260430", "marketing_start_date": "20140206"}